Tag: Daniel Karelitz
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
Goodwin and Nelson Mullins in USD685m Crown LNG SPAC merger
Goodwin Procter and Nelson Mullins Riley & Scarborough have assisted the USD685 million merger of the Oslo-based liquefied natural gas (LNG) offshore terminal
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Strait jacket
Tensions in the Strait of Hormuz reveal fragility of contracts; experts urge rewriting force majeure clauses to safeguard trade supply
